LBPS 02–43 ANGIOTENSIN II RECEPTOR BLOCKER COMBINED WITH CALCIUM CHANNEL BLOCKER IS MORE EFFECTIVE IN REDUCTION OF BLOOD PRESSURE VARIABILITY THAN COMBINED WITH DIURETICS

    loading  Checking for direct PDF access through Ovid

Abstract

Objective:

Hypertensive patients with greater blood pressure variability (BPV) are associated with a higher rate of cardiovascular events. We compared the efficacy of angiotensin II receptor blocker (ARB)/calcium-channel blocker combination with ARB/diuretic combination in reduction of 24-hour BPV.

Design and Method:

In a prospective, randomized, double-blind trial, hypertensive patients were assigned to Losartan/Amlodipine (L/A, dose of 50 mg/5 mg or 100 mg/5 mg) group or Losartan/Hydrochlorothiazide (L/H, dose of 50 mg/12.5 mg or 100 mg/25 mg) group. 24-hour ambulatory BP was measured at baseline and after 20 weeks treatment. BPV was calculated from weighted standard deviation and compared between two groups.

Results:

Total 220 patients [mean age = 59.6 ± 12.3 years, men = 154 (70%)] were enrolled. After 20 weeks treatment, systolic and diastolic weighted standard deviations were significantly lower in L/A group than L/H group. (Table) In multivariate regression analysis, significant difference of diastolic weighted standard deviation after 20 weeks treatment was independent of 24-hour SBP and DBP between two groups.

Conclusions:

ARB/calcium-channel blocker combination is more favorable in reduction of 24-hour BPV than ARB/diuretic combination independent of 24-hour BP differences.

Related Topics

    loading  Loading Related Articles